Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers
1 clinical trials · Condition
◉ Watch Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer (NCT01799278) | Weill Medical College of Cornell University | 2013-02-01 |
Track Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers automatically
Every clearance here is in the API, with alerts when new ones post.